FindTrial
Sign In

The effective and safety maintenance of dose of rush oral immunotherapy of hen's egg allergy

The effective and safety maintenance of dose of rush oral immunotherapy of hen's egg allergy - Rush oral immunotherapy of hen's egg allergy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000040718
Enrollment
40
Registered
2020-06-11
Start date
2019-03-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hen&#39

Interventions

The target maintenance dose 10g of baked egg The target maintenance dose 30g of baked egg

Sponsors

Osaka Habikino medical center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: severe egg allergy patients

Exclusion criteria

Exclusion criteria: patients under rush oral immunotherapy of other food uncontrolled other allergic disease liver and kidney disease patients severe infectionus disease patients IgA deficiency patients Inappropriate patients of doctor's judgement

Design outcomes

Primary

MeasureTime frame
the rate of achievement of target maintenance dose at the end of build-up phase the number of symptoms in build up phase and maitenance phase of six months.—

Countries

Japan

Contacts

Public ContactYuri Takaoka

Osaka Habikino medical center Department of Pediatrics

zvb11075@nifty.com0729572121

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026